top of page
Life Sciences Investors React To Biden Administration’s March-In Decision
After a nine-month review, the Biden administration has reached the unprecedented and misguided conclusion that the 1980 Bayh-Dole Act...
Incubate Coalition
Dec 7, 2023
What Is Up For Biopharmaceutical Policy In 2024?
Incubate and DLA Piper invite you to join us on the morning of Sunday, January 7th, as part of JPM Week 2024. Attendees will gain an...
Incubate Coalition
Nov 20, 2023
Mary R. Grealy On The Small Molecule Penalty, U.S. Dominance In Life Sciences, And More
Incubate Executive Director John Stanford sat down this week with Mary R. Grealy, CEO of the Healthcare Leadership Council, to discuss...
Incubate Coalition
Oct 11, 2023
Incubate Releases Statement On Fitch Ratings’ Analysis Of Medicare Drug Price Negotiations
Fitch Ratings recently released an analysis showing that Medicare's drug price negotiation program is expected to deter investments into...
Incubate Coalition
Sep 25, 2023
Life Sciences Investors React To First 10 Drugs Selected For Government Price Controls
Executive Director John Stanford issued a statement in response. WASHINGTON, D.C. (August 29,2023) — Today, the Centers for Medicare &...
Incubate Coalition
Aug 28, 2023
Incubate Submits Comment In Response To Draft Legislation To Reauthorize PAHPA
Incubate recently submitted comment in response to the Senate HELP Committee’s draft legislation to reauthorize the Pandemic and...
Incubate Coalition
Jul 9, 2023
Massachusetts Biotech Community Calls On Congress To Fix The Small Molecule Penalty
Given the tremendous focus of MA-based companies and investors, we had an opportunity to pen some thoughts which are shared in the...
Incubate Coalition
May 21, 2023
Incubate Submits Comment To CMS Regarding Its Draft Guidance For The Medicare Drug Price Negotiation Program
Incubate submitted our feedback to the Centers for Medicare & Medicaid Services regarding its draft guidance for the Medicare Drug Price...
Incubate Coalition
Apr 16, 2023
The Inflation Reduction Act: Implications For Biopharma Companies And Patients
See our webinar, featuring DLA Piper, on the Inflation Reduction Act healthcare provisions. Incubate hosted a webinar today featuring ...
Incubate Coalition
Sep 22, 2022
Incubate Statement On Amendment 5284 Of The Inflation Reduction Act
Incubate issued the following statement in response to amendment 5284 of the Inflation Reduction Act: Incubate issued the following...
Incubate Coalition
Aug 5, 2022
Incubate Statement On WTO Decision To Suspend Global IP Rights
The Incubate Coalition issued the following statement preceding the WTO TRIPS Council meeting (July 6-7) and following the World Trade...
Incubate Coalition
Jun 29, 2022
Incubate Comment In Response To The FTC’s Request For Comments On The Business Practices Of PBMs
Read Incubate's response to the FTC's Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their...
Incubate Coalition
May 24, 2022
Incubate Executive Director John Stanford Statement In Response To The Centers For Medicare & Medicaid Services’ Devastating Final National Coverage Determination For Certain Alzheimer’s Treatments
See Executive Director John Stanford's statement on CMS' Final NCD on Alzheimer's disease and how this will affect the future of...
Incubate Coalition
Apr 13, 2022
Moonshot Statement
Read Incubate Executive Director John Stanford's statement on President BIden's Moonshot initiative. Incubate Executive Director John...
Incubate Coalition
Feb 2, 2022
Leading Venture Capital Group Concerned With Prescription Drug Deal
"As investors in biotechnology and pharmaceuticals, we're highly concerned about the potential consequences of the new drug-pricing...
Incubate Coalition
Nov 3, 2021
FINAL NIST Oral Testimony – John Stanford, Incubate
We're here today to lend our strong support to the proposed clarification of the appropriate use of "march-in" authority under Bayh Dole....
Incubate Coalition
Feb 25, 2021
Most Favored Nation (MFN) Model Interim Final Rule With Comment Period
Incubate writes to share our strong concerns with the interim final rule (IFR) implementing the Most Favored Nation (MFN) Model. We...
Incubate Coalition
Jan 26, 2021
bottom of page